• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LSAMP 的一种新型基因组改变与非裔美国男性侵袭性前列腺癌相关。

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.

机构信息

Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.

Genomatix Software GmbH, MünchenE D-80335, Germany.

出版信息

EBioMedicine. 2015 Oct 31;2(12):1957-64. doi: 10.1016/j.ebiom.2015.10.028. eCollection 2015 Dec.

DOI:
10.1016/j.ebiom.2015.10.028
PMID:26844274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4703707/
Abstract

Evaluation of cancer genomes in global context is of great interest in light of changing ethnic distribution of the world population. We focused our study on men of African ancestry because of their disproportionately higher rate of prostate cancer (CaP) incidence and mortality. We present a systematic whole genome analyses, revealing alterations that differentiate African American (AA) and Caucasian American (CA) CaP genomes. We discovered a recurrent deletion on chromosome 3q13.31 centering on the LSAMP locus that was prevalent in tumors from AA men (cumulative analyses of 435 patients: whole genome sequence, 14; FISH evaluations, 101; and SNP array, 320 patients). Notably, carriers of this deletion experienced more rapid disease progression. In contrast, PTEN and ERG common driver alterations in CaP were significantly lower in AA prostate tumors compared to prostate tumors from CA. Moreover, the frequency of inter-chromosomal rearrangements was significantly higher in AA than CA tumors. These findings reveal differentially distributed somatic mutations in CaP across ancestral groups, which have implications for precision medicine strategies.

摘要

鉴于世界人口的种族分布正在发生变化,从全球角度评估癌症基因组具有重要意义。我们专注于研究非洲裔男性,因为他们的前列腺癌(CaP)发病率和死亡率不成比例地更高。我们进行了系统的全基因组分析,揭示了区分非裔美国男性(AA)和白种裔美国男性(CA)CaP 基因组的改变。我们发现了染色体 3q13.31 上的一个反复缺失,该缺失以 LSAMP 基因座为中心,在 AA 男性的肿瘤中很常见(对 435 名患者的全基因组序列、14 名患者的 FISH 评估和 320 名患者的 SNP 芯片进行了累积分析)。值得注意的是,携带这种缺失的患者疾病进展更快。相比之下,AA 前列腺肿瘤中 PTEN 和 ERG 常见驱动改变明显低于 CA 前列腺肿瘤。此外,AA 肿瘤中染色体间重排的频率明显高于 CA 肿瘤。这些发现揭示了不同祖裔群体中 CaP 中分布不均的体细胞突变,这对精准医疗策略具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/4703707/d8e5b803c157/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/4703707/699c2b1f3682/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/4703707/4e5f37fe41c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/4703707/d8e5b803c157/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/4703707/699c2b1f3682/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/4703707/4e5f37fe41c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d7/4703707/d8e5b803c157/gr3.jpg

相似文献

1
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.LSAMP 的一种新型基因组改变与非裔美国男性侵袭性前列腺癌相关。
EBioMedicine. 2015 Oct 31;2(12):1957-64. doi: 10.1016/j.ebiom.2015.10.028. eCollection 2015 Dec.
2
Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.源自非裔美国男性的前列腺肿瘤中的独特基因组改变。
Mol Cancer Res. 2020 Dec;18(12):1815-1824. doi: 10.1158/1541-7786.MCR-20-0648. Epub 2020 Oct 28.
3
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.主要具有非洲或欧洲遗传血统的前列腺癌患者的基因组和转录组景观的综合比较。
PLoS Genet. 2020 Feb 14;16(2):e1008641. doi: 10.1371/journal.pgen.1008641. eCollection 2020 Feb.
4
Evidence for molecular differences in prostate cancer between African American and Caucasian men.非裔美国男性和白种男性前列腺癌分子差异的证据。
Clin Cancer Res. 2014 Sep 15;20(18):4925-34. doi: 10.1158/1078-0432.CCR-13-2265. Epub 2014 Jul 23.
5
Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.前列腺癌基因组学:最新进展与少数族裔代表性不足的现状。
Int J Mol Sci. 2018 Apr 22;19(4):1255. doi: 10.3390/ijms19041255.
6
Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.全基因组测序揭示了未经治疗的高危前列腺癌非洲男性中肿瘤突变负担增加和起始驱动突变。
Cancer Res. 2018 Dec 15;78(24):6736-6746. doi: 10.1158/0008-5472.CAN-18-0254. Epub 2018 Sep 14.
7
Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy.接受根治性前列腺切除术的非裔美国人和欧美裔男性中PTEN缺失的患病率及预后意义
Eur Urol. 2017 May;71(5):697-700. doi: 10.1016/j.eururo.2016.07.026. Epub 2016 Jul 28.
8
Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.非洲裔和欧洲裔男性前列腺癌的基因组分析。
Clin Cancer Res. 2020 Sep 1;26(17):4651-4660. doi: 10.1158/1078-0432.CCR-19-4112. Epub 2020 Jul 10.
9
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.白种人和非裔美国前列腺癌患者的原发肿瘤中 ERG 癌蛋白表达频率的差异。
Urology. 2012 Oct;80(4):749-53. doi: 10.1016/j.urology.2012.07.001. Epub 2012 Aug 28.
10
Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion.通过免疫组织化学评估前列腺癌发展和演进过程中的关键改变顺序:PTEN 缺失发生在 ERG 基因融合之后的进一步证据。
Prostate Cancer Prostatic Dis. 2013 Jun;16(2):209-15. doi: 10.1038/pcan.2013.8. Epub 2013 Apr 2.

引用本文的文献

1
Scaling for African Inclusion in High-Throughput Whole Cancer Genome Bioinformatic Workflows.非洲纳入高通量全癌基因组生物信息学工作流程的规模化研究。
Cancers (Basel). 2025 Jul 26;17(15):2481. doi: 10.3390/cancers17152481.
2
Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer.特定血统的DNA损伤修复基因突变与前列腺癌
Cancers (Basel). 2025 Feb 18;17(4):682. doi: 10.3390/cancers17040682.
3
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.非裔美国男性前列腺癌中频繁出现的CHD1缺失与疾病快速进展相关。

本文引用的文献

1
Spatial genomic heterogeneity within localized, multifocal prostate cancer.局限性、多灶性前列腺癌的空间基因组异质性。
Nat Genet. 2015 Jul;47(7):736-45. doi: 10.1038/ng.3315. Epub 2015 May 25.
2
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
3
Cancer statistics, 2015.癌症统计数据,2015 年。
NPJ Precis Oncol. 2024 Sep 19;8(1):208. doi: 10.1038/s41698-024-00705-8.
4
MicroRNAs Associated with IgLON Cell Adhesion Molecule Expression.与IgLON细胞粘附分子表达相关的微小RNA
Curr Issues Mol Biol. 2024 Jul 19;46(7):7702-7718. doi: 10.3390/cimb46070456.
5
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency.非裔美国男性前列腺癌中CHD1缺失频率增加与疾病快速进展相关,且未引发同源重组缺陷。
Res Sq. 2024 Apr 1:rs.3.rs-3995251. doi: 10.21203/rs.3.rs-3995251/v1.
6
Clinical Biofluid Assays for Prostate Cancer.前列腺癌的临床生物流体检测
Cancers (Basel). 2023 Dec 28;16(1):165. doi: 10.3390/cancers16010165.
7
Bioinformatics analysis and experimental validation identified HMGA2/microRNA-200c-3p/LSAMP/Wnt axis as an immunological factor of patients with colorectal cancer.生物信息学分析和实验验证确定HMGA2/微小RNA-200c-3p/LSAMP/ Wnt轴是结直肠癌患者的一个免疫因素。
Am J Cancer Res. 2023 Sep 15;13(9):3898-3920. eCollection 2023.
8
Investigating miR-9 as a mediator in laryngeal cancer health disparities.研究miR-9作为喉癌健康差异的介导因子。
Front Oncol. 2023 Apr 4;13:1096882. doi: 10.3389/fonc.2023.1096882. eCollection 2023.
9
Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer.自报的种族和遗传血统与原发性前列腺癌的免疫基因组景观的关联。
JCI Insight. 2023 Feb 8;8(3):e162409. doi: 10.1172/jci.insight.162409.
10
Identification of recurrent 3q13.31 chromosomal rearrangement indicates as a tumor suppressor gene in neuroblastoma.鉴定出神经母细胞瘤中经常发生的 3q13.31 染色体重排表明 是一种肿瘤抑制基因。
Int J Oncol. 2023 Feb;62(2). doi: 10.3892/ijo.2023.5475. Epub 2023 Jan 5.
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
4
Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma.与神经纤维瘤病1型相关的丛状神经纤维瘤胚胎神经根中的起源细胞。
Cancer Cell. 2014 Nov 10;26(5):695-706. doi: 10.1016/j.ccell.2014.09.009. Epub 2014 Oct 30.
5
COSMIC: exploring the world's knowledge of somatic mutations in human cancer.COSMIC:探索全球关于人类癌症体细胞突变的知识。
Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11. doi: 10.1093/nar/gku1075. Epub 2014 Oct 29.
6
Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.糖原合酶激酶-3β抑制作用可减少前列腺癌干细胞/祖细胞样细胞的数量,并减弱转移生长。
Oncotarget. 2014 Oct 15;5(19):8986-94. doi: 10.18632/oncotarget.1510.
7
Predominance of ERG-negative high-grade prostate cancers in African American men.非裔美国男性中ERG阴性的高级别前列腺癌占主导地位。
Mol Clin Oncol. 2014 Nov;2(6):982-986. doi: 10.3892/mco.2014.378. Epub 2014 Aug 7.
8
Evidence for molecular differences in prostate cancer between African American and Caucasian men.非裔美国男性和白种男性前列腺癌分子差异的证据。
Clin Cancer Res. 2014 Sep 15;20(18):4925-34. doi: 10.1158/1078-0432.CCR-13-2265. Epub 2014 Jul 23.
9
Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.LSAMP的重新表达在临床前骨肉瘤模型中抑制肿瘤生长。
Mol Cancer. 2014 Apr 28;13:93. doi: 10.1186/1476-4598-13-93.
10
SPOP mutations in prostate cancer across demographically diverse patient cohorts.前列腺癌中 SPOP 突变在不同人群患者队列中的情况。
Neoplasia. 2014 Jan;16(1):14-20. doi: 10.1593/neo.131704.